share_log

Doma Holdings Inc. (NYSE:DOMA) Short Interest Up 15.3% in August

Defense World ·  Sep 18, 2022 01:31

Doma Holdings Inc. (NYSE:DOMA – Get Rating) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totalling 8,080,000 shares, a growth of 15.3% from the August 15th total of 7,010,000 shares. Based on an average trading volume of 1,240,000 shares, the days-to-cover ratio is presently 6.5 days. Currently, 11.9% of the shares of the stock are short sold.

Insiders Place Their Bets

In related news, CEO Maxwell Simkoff sold 75,774 shares of Doma stock in a transaction on Tuesday, September 13th. The shares were sold at an average price of $0.59, for a total value of $44,706.66. Following the sale, the chief executive officer now owns 47,017,501 shares in the company, valued at $27,740,325.59. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders have sold 408,175 shares of company stock valued at $309,586. 33.50% of the stock is currently owned by corporate insiders.

Get Doma alerts:

Institutional Investors Weigh In On Doma

Several institutional investors and hedge funds have recently modified their holdings of the company. Allspring Global Investments Holdings LLC acquired a new position in shares of Doma during the 1st quarter worth about $823,000. Advisor Group Holdings Inc. raised its stake in shares of Doma by 6,364.0% during the 4th quarter. Advisor Group Holdings Inc. now owns 16,160 shares of the company's stock worth $82,000 after buying an additional 15,910 shares in the last quarter. Mirabella Financial Services LLP purchased a new position in shares of Doma during the 4th quarter worth approximately $66,000. Providence Capital Advisors LLC purchased a new position in shares of Doma during the 1st quarter worth approximately $67,000. Finally, Gs Investments Inc. purchased a new position in shares of Doma during the 1st quarter worth approximately $49,000. Hedge funds and other institutional investors own 37.73% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on DOMA shares. Compass Point started coverage on Doma in a research note on Wednesday, May 25th. They issued a "neutral" rating and a $2.00 price target for the company. DA Davidson cut their price objective on Doma from $4.25 to $2.50 and set a "buy" rating on the stock in a research report on Wednesday, August 10th.

Doma Stock Down 3.9 %

Shares of NYSE:DOMA opened at $0.55 on Friday. The business has a 50-day moving average price of $0.74 and a 200-day moving average price of $1.44. The stock has a market cap of $178.94 million, a price-to-earnings ratio of -0.96 and a beta of 1.06. Doma has a 52-week low of $0.51 and a 52-week high of $9.10.

Doma (NYSE:DOMA – Get Rating) last issued its quarterly earnings data on Tuesday, August 9th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.06). The business had revenue of $123.74 million during the quarter, compared to analyst estimates of $118.60 million. Doma had a negative net margin of 34.81% and a negative return on equity of 62.96%. As a group, equities analysts anticipate that Doma will post -0.12 EPS for the current fiscal year.

About Doma

(Get Rating)

Doma Holdings Inc originates, underwrites, and provides title, escrow, and settlement services to homeowners, lenders, title agents, and real estate professionals. It operates through two segments, Distribution and Underwriting. The company also engages in title insurance underwriting business, including policies referred through its direct agents and third-party agents' channels; and provides services in the areas of purchase and refinance transactions in the residential real estate market.

Read More

  • Get a free copy of the StockNews.com research report on Doma (DOMA)
  • 3 Banks Worth Considering For Q4
  • Stock Market: 3 Islands Of Strength In A Sea Of Red
  • No One Told These 3 Stocks It's a Down Week
  • MarketBeat: Week in Review 9/12 – 9/16
  • Is There a Cure for What is Ailing Teladoc Stock?

Receive News & Ratings for Doma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doma and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment